Many diseases are polygenic and can only be treated efficiently with drugs that modulate multiple targets. However, rational design of compounds multi-target profiles is rarely pursued because it considered too difficult, in particular if the drug must enter central nervous system. Here, a structure-based strategy to identify dual-target ligands G-protein-coupled receptors presented. We use thi...